EUVIMEDEUVIMED entdecken
Crossref

Cannabidiol reverses microglia activation and deficits of parvalbumin interneurons and their perineuronal nets in a MK-801-induced mouse model of schizophrenia

Naielly Rodrigues da Silva, Davide Gobbo, Felipe V Gomes, Anja Scheller, Frank Kirchhoff, Elaine Del Bel, Francisco Silveira Guimarães

Brain Research · 2025

DOI: 10.1016/j.brainres.2025.149772 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Research, 2025. Verfasst von Naielly Rodrigues da Silva und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil. Electronic address: naiellyrodrigues@alum…. Hauptthemen laut MEDLINE: Cannabidiol, Schizophrenia, Interneurons, Microglia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 141 Literaturangaben. Gefördert von: Universidade de São Paulo, Deutscher Akademischer Austauschdienst, National Institute of Translational Science and Technology in Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabidiol (CBD) has shown potential for treating schizophrenia (SCZ) by targeting its positive and negative cognitive symptoms. In this study, we investigated if CBD could reverse the memory impairment observed after chronic administration of the NMDA receptor antagonist MK-801. Chronic treatment with MK-801 (0.5 mg/kg i.p., twice a day, for 14 days) resulted in short- and long-term memory deficits and decreased relative power of γ oscillations in freely moving animals. CBD administration (30 mg/kg i.p. daily for seven days after the MK-801 treatment period) reversed these changes. The cognitive effects of CBD were prevented by blocking 5-HT1A but not CB2 receptors. At the cellular level, the depletion of parvalbumin-positive neurons and their associated perineuronal nets in the prelimbic medial prefrontal cortex (mPFC) and ventral hippocampus (vHip) induced by MK-801 was reversed by CBD. This neuroprotective effect was mediated by 5-HT1A and CB2 receptors in the vHip but was independent of these receptors in the mPFC. Additionally, CBD reversed MK-801-induced microglial activation in both mPFC and vHip, again through 5-HT1A and CB2 receptors. These findings suggest that CBD modulates multiple pathways affected in SCZ-like conditions, offering a promising therapeutic avenue for SCZ treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolSchizophreniaInterneuronsMicrogliaAnimalsDizocilpine MaleateParvalbuminsMaleMiceDisease Models, AnimalPrefrontal CortexMice, Inbred C57BLHippocampus

Stichwörter der Autor:innen

AM630 (PubChem CID: 4302963)AntipsychoticCBD (PubChem CID: 644019)CannabidiolMK-801 (PubChem CID: 180081)MicrogliaNMDA receptor hypofunctionParvalbumin interneuronsWAY100635 (PubChem CID: 11957721)

Substanzen

CannabidiolDizocilpine MaleateParvalbumins

Autor:innen und Institutionen

  • Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil. Electronic address: naiellyrodrigues@alumni.usp.br.
  • Molecular Physiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), University of Saarland, Homburg, Germany; Center for Gender-specific Biology and Medicine (CGBM), University of Saarland, Homburg,…
  • Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil.
  • Department of Basic and Oral Biology, Faculty of Odontology of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.

Förderung

  • Universidade de São Paulo
  • Deutscher Akademischer Austauschdienst
  • National Institute of Translational Science and Technology in Medicine
  • Northern Research Station
  • H2020 Marie Skłodowska-Curie Actions
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Horizon 2020 Framework Programme
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Rodrigues da Silva, N., Gobbo, D., Gomes, F. V., Scheller, A., Kirchhoff, F., Del Bel, E., & Silveira Guimarães, F. (2025). Cannabidiol reverses microglia activation and deficits of parvalbumin interneurons and their perineuronal nets in a MK-801-induced mouse model of schizophrenia. Brain Research. https://doi.org/10.1016/j.brainres.2025.149772

Vancouver

Rodrigues da Silva N, Gobbo D, Gomes FV, Scheller A, Kirchhoff F, Del Bel E, et al. Cannabidiol reverses microglia activation and deficits of parvalbumin interneurons and their perineuronal nets in a MK-801-induced mouse model of schizophrenia. Brain Research. 2025. doi:10.1016/j.brainres.2025.149772

BibTeX
@article{RodriguesdaSilva2025,
  author = {Rodrigues da Silva, Naielly and Gobbo, Davide and Gomes, Felipe V and Scheller, Anja and Kirchhoff, Frank and Del Bel, Elaine and Silveira Guimarães, Francisco},
  title = {Cannabidiol reverses microglia activation and deficits of parvalbumin interneurons and their perineuronal nets in a MK-801-induced mouse model of schizophrenia},
  journal = {Brain Research},
  year = {2025},
  doi = {10.1016/j.brainres.2025.149772}
}
Kostenlos starten →